INMUNE BIO INC. - COMMON STOCK

INmune Bio, Inc. Announces Participation in Fireside Chat at the B Riley Neurosciences Conference

26 Apr 2021 08:00:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Professor Mark Lowdell, PhD, CSO to Deliver Presentations at Two Upcoming Medical Meetings

22 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Participation at Upcoming Virtual Investor Conferences in March 2021

08 Mar 2021 08:00:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. Announces Fourth Quarter and Full Year 2020 Results and Provides Business Update

04 Mar 2021 15:15:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. to Report Fourth Quarter and Full Year 2020 Financial Results and Provide a Corporate Update on Thursday, March 4

25 Feb 2021 08:00:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. Announces XPro1595 Found to Decrease Neuroinflammation and Neurodegeneration Biomarkers in Patients with Alzheimer’s Disease in Phase 1b Trial

21 Jan 2021 06:00:00 By Nasdaq GlobeNewswire

INmune Bio, Inc. to Host Key Opinion Leader Webinar on Thursday, January 21 at 8 AM ET

13 Jan 2021 07:00:00 By Nasdaq GlobeNewswire